Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07192432 |
| Title | Gene Therapy for HER-Positive Cancer (SENTRY-HER2) (SENTRY-HER2) |
| Acronym | SENTRY-HER2 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Vironexis Biotherapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Valkyrie Clinical Trials | RECRUITING | Los Angeles | California | 90067 | United States | Details |
| SCRI Denver DDU at HealthOne | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| SCRI Oncology Partners | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |